L'Utile Operativo Cambiamento Data
AbbVie USD 6.88B 156M 2026-09
Agenus USD 15.05M 656K 2026-03
Amgen USD 4.68B 65M 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Celldex Therapeutics USD -82.25M 1.63M 2026-09
CSL USD 2.64B 1.97B 2025-12
Eli Lilly USD 12.46B 2.68B 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Glaxosmithkline GBP 2.13B 166M 2026-09
Incyte USD -707.47M 1.41B 2026-09
Intrexon USD -60.84M 26.62M 2024-06
J&J USD 6.47B 1B 2026-09
Jiangsu Hengrui CNY 2.85B 1.17B 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -13.85M 19.59M 2026-06
Merck EUR 660M 437M 2026-09
Merck USD 7.33B 6.49B 2026-09
Northwest Biotherapeutics USD -10.9M 3.42M 2026-03
Novartis USD 5.14B 392M 2026-09
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 662M 5M 2026-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Veracyte USD 18.02M 5.94M 2026-09